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ABSTRACT  
The reaction of [(cymene)RuCl2]2 with K2Hoxonate (H3oxonic: 4,6-dihydroxy-2-carboxy-1,3,5-triazine 
acid) in methanol leads to the formation of the dinuclear half-sandwich ruthenium(II) complex 
[(cymene)2Ru2(µ-Hoxonato)Cl2] (1a).  Removal of the chloride ligands of 1a by treatment with 
AgCF3SO3 yields [(cymene)2Ru2(µ-Hoxonato)(CF3SO3)2] (1b) which, upon posterior reaction with 
N,N’-linkers (L = 4,4’-bipyridine (4,4’-bpy), 4,7-phenantroline (4,7-phen)), gives rise to the formation of 
the tetranuclear open boxes [(cymene)4Ru4(µ-Hoxonato)2(µ-N,N’-L)2](CF3SO3)4 (2a: L = 4,4’-bpy; 2b: 
L = 4,7-phen). These systems have been characterised by 1H NMR, UV-vis and ESI-MS. The single 
crystal structures of the dinuclear precursor 1a and of the clathrate 2b⊂4,7-phen have been determined. 
The interaction of these systems with cysteine, mononucleotides and calf-thymus DNA has been studied 
by means of 1H NMR, UV-vis, circular dicroism, competitive binding assays and AFM imaging. The 
results show that the robust tetracationic ruthenium(II) cyclic systems 2a and 2b do not give ligand 
exchange reactions towards biorelevant ligands. Nevertheless, these systems are able to non-covalently 
bind to DNA, probably at the surface the major groove, inducing significant conformational changes in 
this biomolecule. It is also interesting to note that compounds 2a and 2b, in spite of only giving 
supramolecular interactions with biomolecules, exhibit antitumor activity, particularly, towards the 
human ovarian cancer cell line A2780cisR, showing acquired resistance to cisplatin, with respective 4.6 
and 8.3 microM IC50 values. 
KEYWORDS. Antitumor agents · bioorganometallic chemistry · bioinorganic chemistry· coordination 
cages · supramolecular chemistry. 
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 3 
INTRODUCTION 
The unwished side effects of the treatment of cancer patients with cisplatin and related metallodrugs1
have prompted the research of alternative systems with a different chemical nature. In this regard, the 
organometallic half-sandwich ruthenium(II) complexes of the type [(η6-arene)Ru(YZ)(X)], where YZ is, 
typically, a chelating ligand and X is a halide, are currently the subject of interest as a result of their in 
vitro and in vivo anticancer activity.2 Although, like cisplatin, these systems have also shown to give rise 
to coordinative binding to DNA (through N7 of guanine),3,4 their biological chemistry is quite 
different.4,5 It is also interesting to note the recent report of Therrien and col. on the ability of a half-
sandwich ruthenium based coordination cage to encapsulate [M(acac)2] (M = Pt2+, Pd2+) complexes with 
a synergic enhancement of their antitumor activity.6 On the other hand, we and others have shown that 
polynuclear coordination assemblies like iron(II)7 and ruthenium(II) helicates,8 as well as platinum(II) 
Fujita’s coordination squares9 and metallacalixarenes,10,11 non-covalently bind to DNA with a 
concomitant biological effect (i.e. antitumor activity, telomerase inhibition). Likewise, Fujita and col. 
have very recently reported the isolation effect exerted by Pt(II) coordination cages which strongly 
stabilize the minimal nucleotide duplex formation in highly competitive aqueous solutions.12  
The above mentioned results prompted us to study new examples of systems able to give 
unconventional interactions with biomolecules in order to find out new ways to overcome some 
problems encountered with classical metallodrugs.  In this manuscript, we show a strategy to build a 
series of cationic cyclic polynuclear half-sandwich ruthenium(II) complexes complexes of the 
[(cymene)4Ru4(µ-Hoxonato)2(µ-N,N’-L)2](CF3SO3)4 kind (2a: L = 4,4’-bpy; 2b: L= 4,7-phen), 
containing Hoxonato bridges (H3oxonic: 4,6-dihydroxy-2-carboxy-1,3,5-triazine acid) and N,N’-linkers 
(4,4’-bipyridine (4,4’-bpy), 4,7-phenanthroline (4,7-phen)) (Scheme 1). In addition, we have essayed the 
interaction of these systems with DNA and their citotoxic activity towards human lung and ovarian 
tumor cell lines. We have chosen the Hoxonato system with the purpose of creating a π-acidic surface 
able to give specific interactions with nucleotides through anion-π interactions13 and complementary H-
bonding interactions.14  
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Scheme 1. Formation reaction of the [(cymene)4Ru4(Hoxonato)2(N,N’-L)2](CF3SO3)4 (2a: L = 4,4’-bpy; 
2b: L = 4,7-phen) cyclic assemblies. 
 
EXPERIMENTAL 
Materials 
[(η6-p-cymene)RuCl2)]2 was prepared according to literature methods.15 Oxonic acid potassium salt 
(KH2oxonate), 4,4’-bipyridine (4,4’-bpy) and 4,7-phenanthroline (4,7-phen) were acquired from 
commercial sources and used as received.  
Synthesis 
[(cymene)2Ru2Cl2(Hoxonato)] (1a): [(η6-p-cymene)Ru(Cl)2]2 (612 mg, 1.0 mmol) and oxonic acid 
potassium salt (195 mg, 1 mmol) were suspended in methanol (30 mL). KOH (40 mg, 0.7 mmol) was 
added to the suspension and the resulting mixture was refluxed at 70 ºC for 6h to give, upon cooling, an 
orange precipitate which was filtered off. Crystals suitable for X-ray diffraction were obtained by slow 
evaporation of a CHCl3 solution (544 mg, 78.1% yield). 1H NMR (400 MHz, DMSO-d6, 25 ºC): δ 
(ppm) = 1.08 (m, 12H, CH3-cymene), 2.07 (s, 6H, CH3-cymene), 2.65 (m, 2H, CH-cymene), 5.58 (d, 
2H, aromatic H-cymene), 5.71 (d, 2H, aromatic H-cymene), 5.81 (d, 2H, aromatic H-cymene), 5.92 (d, 
2H, aromatic H-cymene), 11.80 (s, 1H, NH-oxonatoH); elemental analysis calcd (%) for 
C24H31N3O4Cl2Ru2: C 41.26, H 4.47, N 6.02; found: C 41.06, H 4.11, N 6.02. 
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 5 
[(cymene)2Ru2(CF3SO3)2(Hoxonato)]2 (1b): Solid Ag(CF3SO3) (2 mmol, 513 mg) was added to a 
suspension of [(cymene)2Ru2Cl2(Hoxonato)] (1a) (1 mmol, 696 mg) in methanol. The mixture was 
strirred in the dark at 40 ºC for 120 min. Subsequent filtration of AgCl led to isolate an orange solution 
which contained the expected compound. (795 mg, 82.6% yield). 1H NMR (400 MHz, DMSO-d6, 25 
ºC): δ (ppm) = 1.10 (m, 12H, CH3-cymene), 2.08 (m, 6H, CH3-cymene), 2.63 (m, 2H, CH-cymene), 6.06 
(m, 7H, aromatic H-cymene), 6.45 (m, 1H, aromatic H-cymene), 11.87 (s, 1H, NH-oxonatoH); 
elemental analysis calcd (%) for C26H31N3O10S2F6Ru2: C 32.53, H 3.47, N 4.38, S 6.68; found: C 31.29, 
H 3.33, N 4.25, S, 7.21. 
[(cymene)4Ru4(Hoxonato)2(4,4’-bpy)2](CF3SO3)4(H2O)3 (2a): Solid 4,4’-bipyridine (1 mmol, 156 
mg) was added to a solution of compound 1b (1 mmol in 15 mL of MeOH). The resulting solution was 
stirred at room temperature for 24h and then was let stand. After one day, an orange precipitate of 2a 
was isolated. (670 mg, 60.4% yield). 1H NMR (400 MHz, DMSO-d6, 25 ºC): δ (ppm) = 1.15 (dd, 12H, 
CH3-cymene), 1.71 (s, 6H, CH3-cymene), 2.70 (m, 2H, CH-cymene), 5.90 (d, 4H, aromatic H-cymene), 
6.22 (d, 4H, aromatic H-cymene), 7.65 (d, 4H, 4,4’-bpy), 8.06 (d, 4H, 4,4’-bpy), 12.58 (s, 1H, NH-
oxonatoH); FTMS (+ESI): m/z; 931.05 [M - 2CF3SO3]2+. Elemental analysis calcd (%) for 
C72H80N10O23S4F12Ru4: C 39.06, H 3.64, N 6.33, S 5.79; found: C 38.60, H 3.88, N 6.37, S, 6.27. 
[(cymene)4Ru4(oxonatoH)2(4,7-phen)2](CF3SO3)4(CH3OH) (2b): To a solution of compound 1b (1 
mmol in 15 mL of MeOH), was added solid 4,7-phenanthroline (1 mmol, 180 mg). The mixture was 
stirred for 24h to give an orange solid of 2b. (451mg, 40.8% yield).1H NMR (400 MHz, DMSO-d6, 25 
ºC): δ (ppm) = 1.12  (dd, 6H, CH3-cymene), 1.28  (dd, 6H, CH3-cymene), 1.58 (s, 6H, CH-cymene), 
2.07 2.72 (m, 2H, CH-cymene), 5.94 (d, 2H, aromatic H-cymene), 6.19 (d, 2H, aromatic H-cymene), 
6.28  (d, 2H, aromatic H-cymene), 6.52  (d, 2H, aromatic H-cymene), 7.55  (s, 2H, 4,7-phen), 7.69 (m, 
1H, 4,7-phen), 8.07  (s, 2H, 4,7-phen), 8.32  (s, 2H, 4,7-phen), 8.80  (s, 1H, 4,7-phen), 9.07 (s, 2H, 4,7-
phen), 9.18  (d, 1H, 4,7-phen), 12.80 (s, 1H, NH-oxonatoH); FTMS (+ESI): m/z; 955.05 [M - 
2CF3SO3]2+. Elemental analysis calcd (%) for C77H78N10O21S4F12Ru4: C 41.29, H 3.51, N 6.25, S 5.73; 
found: C 42.46, H 3.74, N 6.58, S, 6.11. 
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 6 
Crystals of 2b⊂4,7-phen suitable for X-ray diffraction were grown from a MeOH solution of 2b in 
the presence of an excess of 4,7-phen. 
Characterisation and physical measurements 
The 1H NMR experiments carried out for characterizing compounds 1a, 1b, 2a and 2b and for 
studying the interaction between cyclic systems, nucleotides and cysteine were performed in D2O and 
DMSO-d6 solutions with 10 mg of compound and 0.75 mL of solvent. High temperature experiments 
were run in DMSO-d6 with the aim of studying the conformational flexibility of the cyclic systems.  1H 
NMR spectra were recorded with a BRUKER ARX 400 (400 MHz) (Centre of Scientific 
Instrumentation of the University of Granada). ESI-MS measurements were performed dissolving the 
samples in methanol and measuring on a Waters Micromass LCT Premier mass spectrometer. Elemental 
(C, H, N) analyses were obtained at a FISONS-CARLO ERBA EA 1008 analyzer in the Centre of 
Scientific Instrumentation of the University of Granada. Molecular geometries of compounds 2a and 2b 
were optimised with Molecular Mechanics (MMFF) by using Spartan'04 program package 
(Wavefunction Inc.). 
X-ray crystallography 
Table 1 summarises the crystallographic data for 1a and 2b⊂4,7-phen. The single crystal X-ray 
diffraction data for species 1a were acquired at room temperature from an orange platelet single crystal 
of approximate 0.10×0.10×0.05 mm dimensions, on an Enraf Nonius CAD4 automated diffractometer 
using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The unit cell was determined on the 
basis of the setting angles of 25 randomly distributed reflections in the 9.5<θ<14.4° range. The data 
collection was performed in the 3.0<θ<25.3° range by applying the ω-scan mode [∆ω = 1.1 + 
(0.35tanθ)]. A total of 4678 unique and 3025 observed [I>2σ(I)] reflections were collected [R(int) = 
0.008, R(sigma) = 0.085], and used for the structure solution and the structure refinement (against 316 
parameters). The data were corrected for absorption16 and Lorenz-polarization effects. The structure was 
solved by direct methods17 and refined by full-matrix least-squares on F2.18 All the non-hydrogen atoms 
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 7 
were refined anisotropically. Hydrogen atoms were made riding their parent atoms with an isotropic 
temperature factor 1.2 times that of their parent atoms. 
The single crystal X-ray diffraction data for species 2b⊂4,7-phen were acquired at 100 K from an 
orange prism single crystal of approximate 0.24×0.18×0.14 mm dimensions, on a Bruker APEX 
automated diffractometer using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The data 
collection was performed in the 1.14<θ<26.4° range by applying the ω-scan mode. A total of 19586 
unique and 18078 observed [I>2σ(I)] reflections were collected [R(int) = 0.056, R(sigma) = 0.036], and 
used for the structure solution and the structure refinement (against 1125 parameters). The data were 
corrected for absorption19 and Lorenz-polarization effects. The structure was solved by direct methods17 
and refined by full-matrix least-squares on F2.18 All the non-hydrogen atoms were refined 
anisotropically, but those of the solvent and of the triflate anions (S excluded). Hydrogen atoms were 
made riding their parent atoms with an isotropic temperature factor 1.2 times that of their parent atoms. 
The measured single crystal was twinned (with 0.72:0.28 refined components ratio). A rotational 
disorder of the CF3 and SO3 groups severely affected the triflate anions, an annoying but expected, and 
well documented, phenomenon. The disorder determined the presence of non negligible peaks of 
electron density nearby the triflate anions. Attempts to reasonably model this disorder were not 
successful. Nevertheless, it is worth noting that its presence does not affect the structural features of the 
Ru(II) tetranuclear complex. 
Crystallographic data (excluding structure factors) for species 1a and 2b⊂4,7-phen have been 
deposited with the Cambridge Crystallographic Data Centre as supplementary publication no.s 714114-
714115. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, 
Cambridge CB2 1EZ, UK, (fax: +44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).  
DNA binding studies 
Calf-thymus DNA (ct-DNA) was purchased from Sigma/Aldrich. The ct-DNA was dissolved in water 
without any further purification and kept frozen until the day of the experiment. The ct-DNA 
concentration (moles of bases per litre) was determined spectroscopically by using the molar extinction 
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 8 
coefficients at the maximum of the long-wavelength absorbance (ct-DNA ε258=6600 cm-1mol-1dm3). 
Concentrations of stock solutions of compounds 1b, 2a and 2b were determined from accurately 
weighed samples of these materials. A stock sodium cacodylate buffer (100 mM) was prepared by 
mixing a 50 mL solution of sodium cacodylate (0.2 M, 4.24 g of Na(CH2)2AsO2·3H2O in 100 mL) with 
9.3 mL of hydrochloric acid (0.2 M), and diluting to a total of 100 mL. Stock solutions of 1b, 2a and 2b 
(500 µM) were prepared. All ct-DNA experiments were conducted in sodium cacodylic buffer (1 mM) 
and NaCl (20 mM). Spectroscopic titration series experiments keeping the ct-DNA concentration 
constant were undertaken by adding the salt, buffer, water and the cyclic assembly to the ct-DNA. The 
circular dichroism (CD) spectra were produced by using a Jasco J-715 spectropolarimeter. UV-Vis was 
performed and visualized by ThermoSpectronic UV300 using 2 mL of an aqueous solution of ct-DNA 
(150 µM) in NaCl (20mM) and sodium cacodylate buffer (1 mM). The previously described solutions 
were used to register the UV/Vis spectra adding increased quantities of compounds 2a and 2b and 
keeping the ct-DNA concentration constant (ct-DNA/metal-complexes mixing ratios range from 200:1 
to 5:1). 
 Ethidium bromide (EB) displacement by the cyclic assemblies was calculated by measuring the 
quenching of the EB fluorescence as it leaves the protection of the ct-DNA. A ct-DNA/salts/buffer 
solution with EB (ct-DNA/EB 4:5, 4 mM:5 mM) was prepared. The emission spectrum was recorded as 
a function of 1b, 2a and 2b concentration by using a Variant mod. Cary Eclipse Luminescence 
spectrometer and the ruthenium complex concentration was slowly increased for ct-DNA/metal-
complex ratios from 70:1 to 1:1 keeping the ct-DNA and EB concentrations constant. After each 
addition the fluorescence and UV-visible spectra were recorded (parameters: emission: 600 nm; 
excitation: 540 nm; excitation slit: 10.0 nm; emission slit:15.0 nm).  
Atomic force microscopy imaging (AFM)  
Adsorption of blank calf thymus DNA: Samples were prepared by depositing a drop (10 µL) of a 
ct-DNA solution (30 µM) containing MgCl2 (4 mM) onto a mica sheet. After adsorption for 1 min at 
room temperature, the samples were gently rinsed with milli-Q quality water and dried with nitrogen. 
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 9 
Adsorption of ct-DNA–complexes: Incubation of ct-DNA with 2a and 2b: Solutions of ct-DNA (30 
µM) containing MgCl2 (4 mM) were incubated at room temperature with 2a and 2b (3 
basepairs/complex) for one hour. A drop of these solutions (10 µL) was deposited onto a sheet of mica 
for 1 min. The samples were rinsed and dried as described above. AFM imaging: AFM imaging was 
performed in air by using Tapping Mode on a Multimode Nanoscope IIIa (Veeco, Metrology group) and 
NanoProbe tips (Veeco Inc.). Vibrational noise was reduced with an isolation system (Manfrotto). 
Biological assays 
Cytotoxic studies were performed at the UNIDAD DE EVALUACIÓN DE ACTIVIDADES 
FARMACOLÓGICAS, Instituto de Farmacia Industrial, Facultad de Farmacia, University of Santiago 
de Compostela 15782 Santiago de Compostela, SPAIN. The tumor cell lines A2780, A2780cisR, were 
cultured at 37 ºC in RPMI 1640 medium (Gibco) supplemented with 10% FBS (Fetal Bovine Serum) 
and L-Glutamine 2 mM in an atmosphere of 95% of air and 5% CO2. Cell death was evaluated by using 
a system based on the tetrazolium compound MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2Htetrazolium bromide], which is reduced by living cells to yield a soluble formazan product that can be 
detected colorimetrically. Cells were seeded in 96-well sterile plates at a density of 4000 cells/ well in 
100 µL of medium and were incubated 24 h. Complexes dissolved in DMSO were added to final 
concentrations ranging from 0 to 1.1 10-4 M in a volume of 100 µL/well. The final concentration of 
DMSO in cell culture was maintained in all cases at 1%. 96 h later, 10 µL of a freshly diluted MTT 
solution (2.5 mg/mL) was pipetted into each well and the plate was incubated at 37 °C in a humidified 
5% CO2 atmosphere. After 5 h, the medium was removed and the obtained formazan product was 
dissolved in 100 µL of DMSO. The cell viability was evaluated by measurement of the absorbance at 
595 nm. IC50 values (compound concentration that produces 50% of cell growth inhibition) were 
calculated from curves constructed by plotting cell survival (%) versus drug concentration (µM). All 
experiments were made in triplicate. 
Page 9 of 24
ACS Paragon Plus Environment
Submitted to Inorganic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 10 
 
RESULTS AND DISCUSSION 
Formation and characterisation of the cyclic assemblies 
Reaction of [(cymene)RuCl2]2 with K2Hoxonate in a methanolic solution leads to the formation of the 
dinuclear half-sandwich ruthenium(II) complex [(cymene)2Ru2(µ-Hoxonato)Cl2] (1a). 1a has been 
structurally characterised by single crystal X-ray diffraction. 1a crystallizes in the monoclinic space 
group P21/c. Its asymmetric unit consists of two Ru(II) and two chloride ions, one Hoxonato and two 
cymene moieties, all in general positions. The Hoxonato ligands act in a N,O,N’,O’-exotetradentate 
bridging mode, connecting two Ru(II) ions, 5.6 Å apart, within dinuclear [(cymene)2Ru2(µ-
Hoxonato)Cl2] complexes (Figure 1). The coordination sphere of each metal ion is completed by one 
chloride anion and one η6-cymene ligand, the chloride ions of the dimer adopting a trans disposition 
with respect to the mean plane formed by the two Ru(II) ions and the Hoxonato moiety. Intermolecular 
non bonding interactions of the Cl···N kind are present between one of the two chloride anions of the 
complex and the H(N) hydrogen atom on the Hoxonato ring of an adjacent complex, this imparting 
further stability to the whole crystal structure. 
 
 
Figure 1. Crystal structure of [(cymene)2Ru2(µ-Hoxonato)Cl2] (1a). C (grey), N (blue), O (red), Ru 
(orange), Cl (green). H-atoms with the exception of the NH moiety have been omitted for sake of clarity. 
Page 10 of 24
ACS Paragon Plus Environment
Submitted to Inorganic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 11 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. ESI-MS spectrum and molecular force field model of [(cymene)4Ru4(Hoxonato)2(4,4’-
bpy)2]4+ (2a) and [(cymene)4Ru4(Hoxonato)2(4,7-phen)2]4+ (2b). 
 
 
Figure 3. Crystal structure of the supramolecular assembly [(cymene)4Ru4(Hoxonato)2(4,7-phen)2⊂4,7-
phen]4+ (2b⊂4,7-phen). C (grey), N (blue), O (red), Ru (orange). H-atoms with the exception of the NH 
moiety have been omitted for sake of clarity. 
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Removal of the chloride ligands of 1a by treatment with AgCF3SO3 leads to the formation of 
[(cymene)2Ru2(µ-Hoxonato)(CF3SO3)2] (1b) which, upon posterior reaction with the N,N’-linkers 4,4’-
bpy and 4,7-phen, yields the tetranuclear cage complexes [(cymene)4Ru4(Hoxonato)2(N,N’-
L)2](CF3SO3)4 (2a: L = 4,4’-bpy; 2b: L = 4,7-phen) (Scheme 1). These systems have been studied by 1H 
NMR and ESI-MS and their structures have been modeled by molecular force field modeling (Figure 2). 
The ESI-MS spectra are unequivocally indicative of the formation of the tetranuclear 2a and 2b species. 
Noteworthy, the [M - 2CF3SO3]2+ peaks correspond in both cases to the most intense ones in the mass 
spectra. This feature should be taken as a proof of their high stability. Indeed, 1H NMR spectra for these 
species in both DMSO-d6 and D2O remain unaltered for weeks which agrees with the robustness of 
these systems in both solvents. Noteworthy, in the case of 2b, the 1H NMR experiments indicate the 
presence of two species, which can be attributed to the coexistence of 2b in its cone and 1,3-alternate 
conformations, as confirmed by variable temperature 1H NMR measurements, which shows the 
stabilization of the 1,3-alternate conformer at high temperature.  
The X-ray crystal structure investigation on 2b⊂4,7-phen shows that this species crystallizes in the 
orthorhombic P212121 space group and it is composed by rectangular tetranuclear 
[Ru4(cymene)4(Hoxonato)2(4,7-phen)2]4+ cationic open boxes (Figure 3), in which the Hoxonato and 
4,7-phen ligands show, respectively, N,O,N’,O’-exotetradentate and N4,N7-exobidentate coordination 
modes, bridging Ru(II) centers 5.6 and 7.9 Å apart. The open boxes adopt the cone conformation, 
thereby creating a vase-like cavity suitable for molecular recognition processes. Indeed, the wider 
entrance of the cone hosts one non-coordinated 4,7-phen molecule, whose shortest atom-atom contacts 
with the Hoxonato and 4,7-phen cavity walls are, respectively, 3.0 and 3.2 Å. One methanol molecule is 
placed about the opposite entrance of the cone, while two triflate anions are located nearby. The 
cohesiveness of the structure is granted also by hydrogen bond interactions of the (N)H···O type (N···O 
2.75, 2.76 Å) involving the non bonded nitrogen and oxygen atoms of two Hoxonato ligands belonging 
to distinct, nearby xomplexes. On the whole, each tetramer is hydrogen bonded to two adjacent ones, 
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this creating 1-D zig-zag strands running approximately along [001]. Weaker hydrogen bonds of the 
(O)H···O kind (O···O 3.02 Å) are present between the hydroxyl groups of the solvent molecules and the 
oxygen atoms of nearby triflate anions. 
 
Reactivity and molecular recognition properties of the Ru(II) assemblies towards biorelevant species 
The reactivity of [(cymene)2Ru2(Hoxonato)Cl2] (1a) towards mononucleotides was studied in both 
DMSO and aqueous solution by 1H-NMR at room temperature and at pH 7.0. The results show that the 
chloride ligands do not exchange neither with the solvent nor with the mononucleotides. The addition of 
a nucleotide in deuterated DMSO is responsible for the widening and shifting of the amine proton 
resonance of the triazine moiety, which should be indicative of the formation of H-bonding interactions 
between the Hoxonato moiety and the purine residues of the mononucleotides in low polar solvents like 
DMSO. In contrast to 1a, [(cymene)2Ru2(Hoxonato)(CF3SO3)2] (1b) readily reacts in aqueous solution 
with guanosine monophosphate and adenosine monophosphate to give the corresponding 
[(cymene)2Ru2(Hoxonato)(nucleotide)2] adducts. 
The suitability of compounds 2a and 2b to act as receptors of mononucleotides has been essayed as a 
preliminary model of their non-covalent interaction with DNA. In this regard, the presence of the 
extended aromatic 4,7-phen ligands and the H-bonding features of the Hoxonate moieties suit these 
systems for giving stacking and complementary H-bonding interactions with nucleobases.  
The results show that the addition of a mononucleotide (AMP, GMP) to an aqueous solution of 2a and 
2b is only responsible for a slight upfield shift of the 1H NMR signals, with no observation of ligand 
exchange processes. The latter observation is a further proof of the stability of these systems in aqueous 
solution. Determination of the association constants for the interaction of 2a or 2b with 
mononucleotides in aqueous solution was carried out by means of 1H NMR at pH 7.0.20 The very low 
values Kass < 4 M-1 indicate that the mononucleotides are not incorporated inside the cavity of the 
receptors but probably interact with their external surface through H-bonding, π-π, anion-π and 
electrostatic interactions. It is also important to mention that these systems neither react in aqueous 
Page 13 of 24
ACS Paragon Plus Environment
Submitted to Inorganic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 14 
solution with S-donor ligands. Indeed, 1H NMR studies show that incubation of 2a with 4 equivalents of 
cysteine, during two hours at 37 ºC at pH 7.4, is not responsible for ligand exchange processes. This 
result suggests that S-donor atoms from other biomolecules (i.e. glutathione, proteins) should not 
significantly interfere. 
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DNA binding assays 
 
Figure 4.  Effect of addition of the coordination assemblies [(cymene)4Ru4(Hoxonato)2(4,4’-
bpy)2](CF3SO3)4 (2a, left) and [(cymene)4Ru4(Hoxonato)2(4,7-phen)2](CF3SO3)4 (2b, right) to a solution 
of ct-DNA (34 µM) on the UV-vis spectra in a 200:1 to 7:1 ratio. Subtraction of the coordination 
assemblies spectra has been made. 
 
Figure 5.  CD spectra of the titration of ct-DNA (300 µM) with [(cymene)4Ru4(Hoxonato)2(4,4’-
bpy)2](CF3SO3)4 (2a) and [(cymene)4Ru4(Hoxonato)2(4,7-phen)2](CF3SO3)4 (2b) in a 200:1 to 5:1 ratio. 
 
 
λ λ 
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UV-visible absorbance (UV-vis), circular dichroism (CD) and ethidium bromide (EB) competitive 
binding assays were performed in order to assess the capability of these systems to non-covalently bind 
to DNA. The results indicate that both 2a and 2b do efficiently interact with ct-DNA. The UV-vis 
spectra show an increase in intensity of the characteristic DNA absorption band (λ = 260 nm) upon 
complex addition (Figure 4). Conversely, the CD spectra (Figure 5) show a significant decrease of the 
signal ellipticity as a consequence of the same interaction, particularly in the case of the interaction of 2a 
with DNA. These results might be indicative of conformational changes in the double strand of DNA as 
consequence of a supramolecular interaction between the cyclic systems and DNA.10 In addition, we 
observe, in the case of the interaction of 2a with DNA, a complex induced band (λ = 325 nm), which 
should be taken as a further evidence of the interaction of these systems to DNA. In contrast, 1b is only 
responsible for a slight diminution of the characteristic DNA absorption band despite its capability to 
covalently bind to DNA. AFM imaging experiments on the interaction of 2a and 2b with DNA also 
suggest that the interaction of these systems induce significant changes in the shape of the DNA strands, 
namely stiffening along with strand aggregation (cross-links) (Figure 6). This type of behavior is in 
contrast with the DNA coiling induced by Hannon’s metallocylinders major groove binders,8 but can be 
related to the conformational changes induced by platinum(II) metallacalixarenes.10 Taking into account 
charge, size and shape considerations, 2a and 2b should also fit into the DNA major groove inducing a 
concomitant distortion in the DNA structure.21 Moreover, competitive binding assays show a slight 
diminution in the fluorescence of EB upon complex addition (see Supporting Information). This could 
be related to the displacement of the EB slotted in the DNA major groove in presence of these 
complexes. 
Page 16 of 24
ACS Paragon Plus Environment
Submitted to Inorganic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 17 
 
  
 
Figure 6. AFM images of free ct-DNA (top) and ct-DNA-complexes (ct-DNA–2a (left down) and ct-DNA–2b 
(right down)) at DNA base pairs: complex 3:1 ratio. 
 
Cytotoxicity studies 
To explore the potential biological effects of the interaction of these systems with biomolecules, we 
have evaluated their cytotoxicity on human lung NCI-H460, human ovarian A2780 and A2780cisR 
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cancer cell lines. IC50 data are reported in Table 2. These systems are not active towards the lung 
carcinoma NCI-H460 cell line. In the case of the ovarian A2780 cancer cells, it is interesting to observe 
that, while compound 1a is not active, compounds 1b, 2a and 2b show cytotoxic activity against this 
cell line, although the activities are 20-30 times lower than those exhibited by cisplatin. Noteworthy, the 
activity of 1b, 2a and 2b systems towards the A2780cisR cancer cell line with acquired resistance to 
cisplatin is significantly higher, which give rise to unusually low RF values.22 The lack of cytotoxic 
activity of 1a was expected in view of its inertness to exchange processes (see above); by contrast, the 
activity of compounds 2a and 2b towards A2780 cancer cell line is quite striking in view of the non-
covalent nature of their interaction to DNA. Moreover, their high activity towards the cisplatin resistant 
A2780cisR cancer cell line and the very low resistance factors (RF) might be indicate efficient 
circunvection of cisplatin resistance.23 On the other hand the poor activity of these systems towards the 
lung NCI-H460 cell line might be indicative of a low toxicity of these systems, These features might be 
taken as a proof of a differentiated mechanism of action of 2a and 2b with respect to classical 
metallodrugs. In this regard, it should be noted that ruthenium metallodrugs, that are currently in clinical 
trials (NAMI-A and KP1019), like cisplatin, possess chloride ligands that can be exchanged in order to 
bind to biomolecules. It is therefore of high interest to find systems with alternative mechanisms of 
action. Non-covalent binding of metallodrugs to DNA is an attractive approach; however, most of the 
effort has been focused on intercalators, with a few exceptions being Hannon’s major groove binders of 
metallocyclinder type6 and our recent report on platinum(II) metallacalixarenes.8,9  
 
CONCLUSIONS 
We have prepared a series of robust organometallic/coordination Ru(II) cyclic assemblies which do 
not give ligand exchange reactions neither with N-donor biorelevant ligands (nucleobases), nor with S-
donor biorelevant ligands (cysteine) in aqueous solutions. Nevertheless, these systems are able to 
interact non-covalently with DNA, inducing significant conformational changes in this biomolecule. 
These results also imply that different supramolecular drug designs might be used to induce different 
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DNA structural effects. Moreover, the cytotoxic activity towards cisplatin resistant cancer cells suggests 
that metal coordination assemblies able to bind non-covalently to biomolecules may be a very promising 
field of research, which may circumvent the heavy metal accumulation problems of platinum and related 
metallodrugs. It should also be highlighted that the inactivity of these systems towards lung carcinoma 
NCI-H460 cell lines might be indicative that this kind of systems are not highly citotoxic and might be 
selective towards specific cell lines. 
Work is in progress in order to systematically control the shape and size of this kind of assemblies and 
to study if there is a DNA binding sequence specificity. 
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Table 1: Crystallographic data and refinement parameters for species 1a and 2b⊂4,7-phen. 
 
 1a 2b⊂4,7-phen 
formula C24H28Cl2N3O4Ru2 C89H88F12N12O21Ru4S4 
FW (g mol-1) 695.5 2422.3 
T (K) 298(2) 100(2) 
λ (Å) 0.71073 0.71073 
crystal system Monoclinic orthorhombic 
space group P 21/c P 212121 
a (Å) 12.609(2) 14.1402(5) 
b (Å) 12.810(4) 21.9479(6) 
c (Å) 16.720(6) 30.7251(9) 
α (deg) 90 90 
β (deg) 107.35(2) 90 
γ (deg) 90 90 
V(Å3) 2578(1) 9535.5(5) 
Z 4 4 
ρ(calc) (Mg m-3) 1.415 1.687 
µ (Mo-Kα, mm-1 ) 1792 0.810 
F(000) 1388 4888 
Sample Size (mm3) 0.10×0.10×0.05 0.24×0.18×0.14 
2θ range (deg) 6.0 – 50.6 2.28 - 52.8 
hkl range 
-15 ≤ h ≤ 14 
-3 ≤ k ≤ 15 
-8 ≤ l ≤ 20 
-17 ≤ h ≤ 17 
-27 ≤ k ≤ 27 
-38 ≤ l ≤ 38 
unique, observed reflections 4678, 3025 19586, 18078 
R(int), R(sigma) 0.008, 0.085 0.056, 0.036 
data, restrains, parameters 4678, 0, 316 19586, 0, 1102 
χ(F2) a 1.044 1.611 
R(F), wR(F2) for I > 2σ(I) [a] 0.052, 0.087 0.065, 0.193 
R(F), wR(F2) for all reflections [a] 0.103, 0.102 0.071, 0.197 
highest peak, deepest hole (e Å-3) 0.653, -0.611 4.01, -1.65 
 
[a] χ(F2) = [Σw(Fo2 – Fc2)2/(n – p)]1/2 where n is the number of reflections, p the number of parameters 
and w = 1/[σ2(Fo2) + (0.019P)2 + 1.88P] with P = (Fo2 + 2Fc2)/3. R(F) = Σ||Fo| – |Fc||/Σ|Fo| and wR(F2) = 
[Σw(Fo2 - Fc2)2/ΣwFo4]1/2. 
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Table 2. IC50a values (in µM) in lung NCI-H460, ovarian A2780 and cisplatin resistant A2780cisR 
cancer cell lines and resistence factor RF (IC50 cisplatin resistant / IC50 cisplatin sensitive). 
Compound[a] NCI-H460 A2780 A2780cisR RF  
1a >100 µM >100 µM >100 µM -  
1b 
2a 
2b 
Cisplatin 
- 
>100 µM 
>100 µM 
5.7 
20 
19 
15 
0.66 
2.4 
4.6 
8.3 
3.7 
0.12 
0.24 
0.55 
5.61 
 
a
 IC50 : drug concentration necessary for 50% inhibition of cell viability. 
 
SYNOPSIS TOC   
Robust tetracationic ruthenium(II) cyclic systems are able to bind non-covalently to the major groove of 
DNA inducing conformational changes in this biomolecule, and exhibit cytotoxic activity towards 
ovarian cancer cell line with acquired cisplatin resistance A2780cisR. 
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